Literature DB >> 20606003

Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide.

Ryoko Sawamura1, Noriko Okudaira, Kengo Watanabe, Takahiro Murai, Yoshimasa Kobayashi, Masaya Tachibana, Takashi Ohnuki, Kayoko Masuda, Hidehito Honma, Atsushi Kurihara, Osamu Okazaki.   

Abstract

Acyl glucuronides (AGs) formed from carboxylic acid-containing drugs have been considered to be a cause of idiosyncratic drug toxicity (IDT). Chemical stability of AGs is supposed to relate to their reactivity. In this study, the half-lives of 21 AGs of carboxylic drugs in potassium phosphate buffer (KPB), human serum albumin (HSA) solution, and human fresh plasma were analyzed in relation to the IDT risk derived from these drugs. The carboxylic drugs were classified into three safety categories of "safe," "warning," and "withdrawn" in terms of their IDT risk. As for the results, the half-lives of AGs in KPB correlated with the IDT risk better than those in HSA solution or in human fresh plasma with regard to the separation of the safe drugs from the warning drugs or the withdrawn drugs. In KPB, whereas the half-lives in the safe category were 7.2 h or longer, those in the withdrawn category were 1.7 h or shorter. The classification value of the half-life in KPB, which separated the safe drugs from the withdrawn drugs was calculated to be 3.6 h by regression analysis. In conclusion, this is the first report that clearly shows the relationship between the IDT risk and chemical stability of AGs in several in vitro systems. The KPB system was considered to be the best for evaluating the stability of AGs, and the classification value of the half-life in KPB serves as a useful key predictor for the IDT risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606003     DOI: 10.1124/dmd.110.034173

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  12 in total

Review 1.  Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.

Authors:  Thomas A Baillie; Allan E Rettie
Journal:  Drug Metab Pharmacokinet       Date:  2010-10-22       Impact factor: 3.614

2.  Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).

Authors:  Jin Zhou; Upendra A Argikar; John O Miners
Journal:  Methods Mol Biol       Date:  2021

3.  In Vitro Metabolism of Montelukast by Cytochrome P450s and UDP-Glucuronosyltransferases.

Authors:  Josiane de Oliveira Cardoso; Regina Vincenzi Oliveira; Jessica Bo Li Lu; Zeruesenay Desta
Journal:  Drug Metab Dispos       Date:  2015-12       Impact factor: 3.922

4.  Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Authors:  Thomas G Hammond; Xiaoli Meng; Rosalind E Jenkins; James L Maggs; Anahi Santoyo Castelazo; Sophie L Regan; Stuart N L Bennett; Caroline J Earnshaw; Guruprasad P Aithal; Ira Pande; J Gerry Kenna; Andrew V Stachulski; B Kevin Park; Dominic P Williams
Journal:  J Pharmacol Exp Ther       Date:  2014-06-05       Impact factor: 4.030

5.  Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids.

Authors:  Stefano Crosignani; Catherine Jorand-Lebrun; Gordon Campbell; Adeline Prêtre; Tania Grippi-Vallotton; Anna Quattropani; Gwenaelle Bouscary-Desforges; Agnes Bombrun; Marc Missotten; Yves Humbert; Christèle Frémaux; Mikaël Pâquet; Kamel El Harkani; Charles G Bradshaw; Christophe Cleva; Nada Abla; Hamina Daff; Olivier Schott; Pierre-André Pittet; Jean-François Arrighi; Marilène Gaudet; Zoë Johnson
Journal:  ACS Med Chem Lett       Date:  2011-10-10       Impact factor: 4.345

6.  In silico prediction of acyl glucuronide reactivity.

Authors:  Tim Potter; Richard Lewis; Tim Luker; Roger Bonnert; Michael A Bernstein; Timothy N Birkinshaw; Stephen Thom; Mark Wenlock; Stuart Paine
Journal:  J Comput Aided Mol Des       Date:  2011-10-26       Impact factor: 3.686

7.  The Application of Mass Spectrometry in Drug Metabolism and Pharmacokinetics.

Authors:  Ji-Yoon Lee; Sang Kyum Kim; Kiho Lee; Soo Jin Oh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Metabolic profiling of praziquantel enantiomers.

Authors:  Haina Wang; Zhong-Ze Fang; Yang Zheng; Kun Zhou; Changyan Hu; Kristopher W Krausz; Dequn Sun; Jeffrey R Idle; Frank J Gonzalez
Journal:  Biochem Pharmacol       Date:  2014-05-10       Impact factor: 5.858

9.  Impacts of diphenylamine NSAID halogenation on bioactivation risks.

Authors:  Mary Alexandra Schleiff; Sasin Payakachat; Benjamin Mark Schleiff; S Joshua Swamidass; Gunnar Boysen; Grover Paul Miller
Journal:  Toxicology       Date:  2021-06-06       Impact factor: 4.571

10.  Discovery and Optimization of Highly Potent and Selective AT2R Antagonists to Relieve Peripheral Neuropathic Pain.

Authors:  Yanghui Guo; Xiangui Huang; Weiwei Liao; Lichen Meng; Daiwang Xu; Cheng Ye; Lei Chen; Taishan Hu
Journal:  ACS Omega       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.